Benefitfocus Names Barry Libert to Board of Directors
CHARLESTON, S.C., Sept. 15, 2020 (GLOBE NEWSWIRE) — Benefitfocus, Inc. (NASDAQ: BNFT), a leading cloud-based benefits technology platform enabling rapid […]
Landec Corporation Sets First Quarter 2021 Earnings Conference Call for October 6, 2020 at 2 p.m. PT
SANTA MARIA, Calif., Sept. 15, 2020 (GLOBE NEWSWIRE) — Landec Corporation (Nasdaq: LNDC), a diversified health and wellness company with […]
LPL Financial Reports Monthly Activity for August 2020
SAN DIEGO, Sept. 15, 2020 (GLOBE NEWSWIRE) — Leading retail investment advisory firm and independent broker-dealer LPL Financial LLC, a […]
Apex Global Brands Reports Second Quarter 2021 Financial Results
Second Quarter Fiscal 2021 Highlights versus Second Quarter Fiscal 2020: Revenues declined to $4.4 million from $5.6 millionAdjusted EBITDA decreased to […]
Avid Bioservices Announces Move to Virtual-Only Annual Meeting of Stockholders on October 20, 2020
TUSTIN, Calif., Sept. 15, 2020 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), today announced that it will hold its 2020 […]
RLH Corporation Appoints Chris Trick Chief Marketing Officer
DENVER, Sept. 15, 2020 (GLOBE NEWSWIRE) — RLH Corporation (NYSE:RLH) announced today the appointment of Christopher (Chris) Trick as its […]
Kelly® to Participate in Sidoti Fall 2020 Virtual Investor Conference
TROY, Mich., Sept. 15, 2020 (GLOBE NEWSWIRE) — Kelly (Nasdaq: KELYA) (Nasdaq: KELYB), a leading specialty talent solutions provider, today […]
Teradyne Announces Senior Management Changes
NORTH READING, Mass., Sept. 15, 2020 (GLOBE NEWSWIRE) — Teradyne, Inc. (Nasdaq: TER) today announced two senior management changes. Gregory […]
PRA Health Sciences Announces Appointment of New Director
RALEIGH, N.C., Sept. 15, 2020 (GLOBE NEWSWIRE) — PRA Health Sciences, Inc. (NASDAQ:PRAH) today announced the appointment of Glen Stettin, […]
Voyager Therapeutics Appoints Nancy Vitale to its Board of Directors
CAMBRIDGE, Mass., Sept. 15, 2020 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on […]
